Wechselwirkungen der intestinalen Mikroflora und des angeborenen Immunsystems bei entzündlichen Erkrankungen im GastrointestinaltraktAndré Fischer11.11447#2742530#3991.23336#3794604#3821.31.451.51.66262.12.1.12.1.272.1.382.1.492.1.52.1.62.1.7102.22.2.12.2.22.32.3.1112.3.22.3.32.3.412604#4902.3.52.3.6132.3.72.3.8 Literaturverzeichnis Abbas AK, Murphy KM, Sher A (1996 ). Functional diversity of helper T lymphocytes. Nature;383(6603):787-93. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M (2001). Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol; 167(3):1609-16. Abreu MT, Fukata M, Arditi M (2005). TLR signaling in the gut in health and disease. J Immunol; 174(8):4453-60. Aebischer T, Schmitt A, Walduck AK, Meyer TF (2005). Helicobacter pylori vaccine development: facing the challenge . Int J Med Microbiol; 295(5):343-53. Aebischer T, Fischer A, Walduck A, Schlötelburg C, Lindig M, Schreiber S, Meyer TF, Bereswill S, Göbel UB (2006). Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. FEMS Immunol Med Microbiol; 46(2):221-9. Ahmad R, Qureshi HY, El Mabrouk M, Sylvester J, Ahmad M, Zafarullah M (2006). Interferon gamma inhibits interleukin-1-induced MMP-13 expression in human articular chondrocytes via receptor-mediated STAT-1 activation and interaction with CBP/P300 coactivator. Ann Rheum Dis ; (Epub ahead of print) Akira S, Takeda K, Kaisho T (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol; 2:675-80. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res.; 25:3389-3402. Amann RI, Ludwig W, Schleifer KH (1995 ). Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev; 59:143-169. Anceriz N, Vandal K, Tessier PA (2007). S100A9 mediates neutrophil adhesion to fibronectin through activation of beta2 integrins. Biochem Biophys Res Commun ; (Epub ahead of print) Angelakopoulos H, Hohmann EL (2000). Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun; 68(4):2135-41. Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, Iiyama R, Totsuka T, Takeda K, Akira S, Watanabe M (2005). MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol; 40(1):16-23. Axelsson LG, Landstrom E, Goldschmidt TJ, Gronberg A, Bylund-Fellenius AC (1996 ). Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(1)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res; 45:181–191. Bamias G, Marini M, Moskaluk CA, Odashima M, Ross WG, Rivera-Nieves J, Cominelli F (2002). Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J Immunol; 169:5308-14. Barnich N, Boudeau J, Claret L, Darfeuille-Michaud A. (2003). Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. Mol Microbiol 48:781-794. Barnich N, Darfeuille-Michaud A (2007). Adherent-invasive Escherichia coli and Crohn's disease. Curr Opin Gastroenterol; 23(1):16-20. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW (1999). Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood;93:3267-75. Bennouna S, Sukhumavasi W, Denkers EY (2006 ). Toxoplasma gondii inhibits toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils. Infect Immun; 74(7):4274-81. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB (2005a). VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol;100(7):1539-46. Bibiloni R, Simon MA, Albright C, Sartor B, Tannock GW (2005b). Analysis of the large bowel microbiota of colitic mice using PCR/DGGE . Lett Appl Microbiol;41(1):45-51. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW (2006). The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol; 55(Pt 8):1141-9. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA (2006). Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci; 103(3):732-7. Bodhidatta L, Hoge CW, Churnratanakul S, Nirdnoy W, Sampathanakul P, Tungtaem C, Raktham S, Smith CD, Echeverria P (1993). Diagnosis of Helicobacter pylori infection in a developing country: comparison of two ELISAs and a seroprevalence study . J Infect Dis 168;1549-1553. Bohn E, Bechtold O, Zahir N, Frick JS, Reimann J, Jilge B, Autenrieth IB (2006). Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures. Inflamm Bowel Dis; 12(9):853-62. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A (1999) Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 67:4499-4509. Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A (2003). Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment Pharmacol Ther; 18(1):45-56. Boyle JS, Lew AM (1995). An inexpensive alternative to glassmilk for DNA purification . Trends Genet; 11(1):8. Bringer MA, Glasser AL, Tung CH, Meresse S, Darfeuille-Michaud A (2006). The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages. Cell Microbiol; 8(3):471-84. Brown LM (2000). Helicobacter pylori: epidemiology and routes of transmission . Epidemiol Rev;22:283-97. Bull AT, Ward AC, Goodfellow M (2000). Search and discovery strategies for biotechnology: The paradigm shift. Microbiol Mol Biol Rev 64:573-606. Bumann D, Metzger WG, Mansouri E, Palme O, Wendland M, Hurwitz R, Haas G, Aebischer T, von Specht BU, Meyer TF ( 2001). Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine;20(5-6):845-52. Buzoni-Gatel D, Debbabi H, Mennechet FJ, Martin V, Lepage AC, Schwartzman JD, Kasper LH (2001). Murine ileitis after intracellular parasite infection is controlled by TGF-beta-producing intraepithelial lymphocytes. Gastroenterology; 120(4):914-24. Buzoni-Gatel D, Werts C (2006). Toxoplasma gondii and subversion of the immune system. Trends Parasitol; 22(10):448-52. Campieri M, Gionchetti P. 2001 . Bacteria as the cause of ulcerative colitis. Gut 48:132-135. Chang NC, Hung SI, Hwa KY, Kato I, Chen JE, Liu CH, Chang AC (2001 ). A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem; 276(20):17497-506. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL (1994). Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science;265(5176):1237-40. Cole JR, Chai B, Farris RJ, Wang Q, Kulam-Syed-Mohideen AS, McGarrell DM, Bandela AM, Cardenas E, Garrity GM, Tiedje JM (2006). The ribosomal database project (RDP-II): introducing myRDP space and qualitycontrolled public data. Nucleic Acids Res. 2006 Nov 7; [Epub ahead of print] Cooper HS, Murthy SNS, Shah RS, Sedergran DJ (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238–249. Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process — First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res; 52:6735–6740. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987). Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut;28:1221-1227. Czeslick E, Struppert A, Simm A, Sablotzki A (2006 ). E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes. Inflamm Res; 55(11):511-5. Dahllof I (2002). Molecular community analysis of microbial diversity. Curr Opin Biotechnol; 13(3):213-7. Dalhoff A, Shalit I (2003). Immunomodulatory effects of quinolones. Lancet Infect Dis; 3(6):359-71. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology;115:1405-1413. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology;127:412-21. David SA (2001). Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules. J Mol Recognit; 14(6):370-87. Del Giudice G, Covacci A, Telford JL, Montecucco C,, Rappuoli R (2001). The design of vaccines against Helicobacter pylori and their development. Annual Review of Immunology 19:523-63., 523-563. DeLong EF, Pace NR (2001). Environmental diversity of bacteria and archaea. Syst Biol; 50(4):470-8. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ (1997). T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol; 150(1):91-7. Dickson I, Alper CA (1974). Changes in serum proteinase inhibitor levels following bone surgery. Clin Chim Acta; 54(3):381-5. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO (1994). Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology;107:1643–1652. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, Van Rees EP (1998). Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol; 114:385–391. Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, Sartor RB (2003). Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut;52:370-6. DiPetrillo MD, Tibbetts T, Kleanthous H, Killeen KP, Hohmann EL (1999). Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine;18(5-6):449-59. Dojka MA, Harris JK, Pace NR (2000). Expanding the known diversity and environmental distribution of an uncultured phylogenetic division of bacteria. Appl Environ Microbiol;66:1617-1621. Donskey CJ, Hujer AM, Das SM, Pultz NJ, Bonomo RA, Rice LB (2003). Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol. Methods; 54:249-256. Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM (1990). Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med;322:359-363. Drumm B, Rowland M (2003). The epidemiology of Helicobacter pylori: where to from here? J Pediatr Gastroenterol Nutr;36(1):7-8. Dykhuizen DE (1998). Santa Rosalia revisited: why are there so many species of bacteria? Antonie van Leeuwenhoek; 73:25–33. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005). Diversity of the human intestinal microbial flora. Science;308(5728):1635-8. El Omar EM, Oien K, El Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE (1997). Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology;113:15-24. Elson CO, Cong Y, Iqbal N, Weaver CT (2001). Immuno-bacterial homeostasis in the gut: new insights into an old enigma. Semin Immunol 13:187-94. Elson CO, Konrad A, Cong Y, Weaver CT (2004). Gene disruption and immunity in experimental colitis. Inflamm Bowel Dis; 10 Suppl 1:S25-8. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT (2005). Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev; 206:260-76. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP (1998). Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J.Exp.Med; 188:2277-2288. Ernst PB, Gold BD (2000). The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu.Rev.Microbiol. 54:615-40., 615-640. Ewaschuk JB, Tejpar QZ, Soo I, Madsen K, Fedorak RN (2006a). The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Curr Gastroenterol Rep;8(6):486-98. Ewaschuk JB, Dieleman LA (2006b). Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol;12(37):5941-50. Feldman M, Cryer B, McArthur KE, Huet BA, Lee E (1996). Effects of aging and gastritis on gastric acid and pepsin sretion in humans: a prospective study. Gastroenterology;110:1043-1052. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A (1995). The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci; 92(14):6499-503. Finegold SM, Rolfe RD (1983). Susceptibility testing of anaerobic bacteria. Diagn. Microbiol. Infect. Dis; 1:33-40. Firestein GS, Roeder WD, Laxer JA, Townsend KS, Weaver CT, Hom JT, Linton J, Torbett BE, Glasebrook AL (1989). A new murine CD4+ T cell subset with a restricted cytokine profile. J Immunol; 143(2):518-25. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL,Strong RK, Walsh CT, Aderem A, Smith KD (2006). The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci; 103(44):16502-7. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A (2004). Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature;432(7019):917-21. Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, Walker WA, Fedorak RN, Camilleri M (2006). Recommendations for probiotic use . J Clin Gastroenterol;40(3):275-8. Fort MM, Mozaffarian A, Stover AG, Correia Jda S, Johnson DA, Crane RT, Ulevitch RJ, Persing DH, Bielefeldt-Ohmann H, Probst P, Jeffery E, Fling SP, Hershberg RM (2005). A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 15;174(10):6416-23. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, Rutgeerts P. (2004). Deficient host-bacteria interactions in inflammatory bowel disease ? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut;53(7):987-92. Franks AH, Harmsen HJM, Raangs GC, Jamsen GJ, Schut F, Welling GW (1998). Variations in bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16SrRNA.targeted oligonucleotide probes. Appl Environ Microbiol;64:3336-3340. Frick JS, Zahir N, Muller M, Kahl F, Bechtold O, Lutz MB, Kirschning CJ, Reimann J, Jilge B, Bohn E, Autenrieth IB (2006). Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6. Eur J Immunol;36(6):1537-47. Fuchs, David . Die Rolle kommensaler Darmbakterien bei der Immunpathogenese der akuten Ileitis nach oraler Infektion der Maus mit Toxoplasma gondi. Medizinische Dissertationsschrift, FU/HU Berlin, in Vorbereitung. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W (1996). Disparate CD4+ lamina propria (LP) lymphokine sretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased sretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased sretion of IL-5. J Immunol; 157:1261–1270 Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, Yang Z, Exley M, Kitani A, Blumberg RS, Mannon P, Strober W (2004). Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical TH2 response in ulcerative colitis. J Clin Invest 113:1490–1497. Gerbitz A, Schultz M, Wilke A, Linde HJ, Schölmerich J, Andreesen R, Holler E (2004) Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 103:4365-4367. Gewirtz AT, Madara JL (2001). Periscope up - monitoring microbes in the intestine. Nature Immunol; 2:288-290. Gionchetti P, Rizzello F, Venturi A, Campieri M (2000). Probiotics in infective diarrhoea and inflammatory bowel diseases. J Gastroenterol Hepatol; 15(5):489-93. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A (2001). Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun; 69(9):5529-37. Gomez-Duarte OG, Lucas B, Yan ZX, Panthel K, Haas R, Meyer TF (1998). Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine;16(5):460-71. Goodman KJ, Cockburn M (2001 ). The role of epidemiology in understanding the health effects of Helicobacter pylori. Epidemiology;12(2):266-71. Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR, Wiedenmann B, Dignass AU, Sturm A (2006). Escherichia coli strain nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect. Immun. 74:4075-4082. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982). Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal. Biochem 126: 131-138 Greenbloom SL, Steinhart AH, Greenberg GR (1998). Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 1998;12:53-6. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature;389(6652): 737-42. Hallman M, Rämet M, Ezekowitz RA (2001). Toll-like receptors as sensors of pathogens. Pediatr Res; 50: 315-321. Hampe J, Cuthbert A, Croucher PJP, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJS, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG (2001). Association between insertion mutation in NOD2 gene and Crohn´s disease in german and british populations. Lancet; 357 :1925-8. Hans W, Schölmerich J, Gross V, Falk W (2000a). The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice . Eur. J. Gastroenterol. Hepato;12 :267-273. Hans W, Schölmerich J, Gross V, Falk W (2000b). Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur Cytokine Netw;11(1):67-74. Hattori T, Mitsui H, Haga H, Wakao N, Shikano S, Gorlach K, Kasahara Y, El-Beltagy A, Hattori R (1997). Advances in soil microbial ecology and the biodiversity. Antonie Van Leeuwenhoek;72:21-28. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn HK, Dunay IR, Moter A, Gescher DM, Schumann RR, Göbel UB, Liesenfeld O (2006). Gram-negative bacteria aggravate murine small intestinal Th1-Type immunopathology following oral infection with Toxoplasma gondii. J Immunol; 177:8785-8795 Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, Liesenfeld O, Schumann RR, Göbel UB, Bereswill S (2007 ). Exacerbation of Murine Ileitis By Toll-Like Receptor 4 Mediated Sensing of Lipopolysaccharide From Commensal Escherichia coli. Gut;56(7):941-8. Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, Jahn HK, Freudenberg M, Loddenkemper C, Batra A, Lehr HA, Liesenfeld O, Blaut M, Göbel UB, Schumann RR, Bereswill S (2007b). Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4. PloS ONE; 2:e662 Hoentjen F, Harmsen HJ, Braat H, Torrice CD, Mann BA, Sartor RB, Dieleman LA (2003). Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice. Gut;52:1721-7. Hogan SP, Seidu L, Blanchard C, Groschwitz K, Mishra A, Karow ML, Ahrens R, Artis D, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rothenberg ME (2006). Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol; 118(1):257-68. Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn J, Eissner G, Schölmerich J, Andreesen R (2004). Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood;104:889-894. Hopkins MJ, Sharp R, Macfarlane GT (2001). Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community fatty acid profiles. Gut;48:198-205. Hugenholtz P, Goebel BM, Pace NR (1998a). Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol; 180:4765-4774. Hugenholtz P, Pitulle C, Hershberger KL, Pace NR(1998b). Novel division level bacterial diversity in a Yellowstone hot spring. J Bacteriol 180:366-376. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O´Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn´s disease Nature;411:599-603. Hugot JP (2006). CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci;1072:9-18. Hunter-Cevera, JC (1998). The value of microbial diversty. Curr Opin Microbiol; 1:278-285. Husebye E (2005). The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy; 51 Suppl 1:1-22. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T (2000). Microbial lipopeptides induce the production of IL-17 in Th cells . J Immunol;165(11):6107-15. Ingrassia I, Leplingard A, Darfeuille-Michaud A (2005). Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl Environ Microbiol; 71(6):2880-7. Inohara N, Ogura Y, Chen FF, Muto A, Nunez G (2001 ) Human Nod1 confers responsiveness to bacterial lipopolysaccharides J Biol Chem; 276:2551-4 Iovanna JL & Dagorn JC (2005). The multifunctional family of sreted proteins containing a C-type lectin-like domain linked to a short N-terminal peptide. Biochim Biophys Acta; 1723(1-3):8-18. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Furll B, Freudenberg M, Schmitz G, Stelter F, Schutt C (1997). Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature;389(6652):742-5. Kaisho T, Akira S (2003). Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med; 3:373-385. Kamradt T, Burmester GR (1998). Cytokines and arthritis: is the Th1/Th2 paradigm useful for understanding pathogenesis? J Rheumatol; 25(1):6-8. Kasper L, Courret N, Darche S, Luangsay S, Mennechet F, Minns L, Rachinel N, Ronet C, Buzoni-Gatel D (2004). Toxoplasma gondii and mucosal immunity. Int J Parasitol; 34(3):401-9. Kayama S, Mitsuyama M, Sato N, Hatakeyama K (2000). Overgrowth and translocation of Escherichia coli from intestine during prolonged enteral feeding in rats. J Gastroenterol; 35:15-9. Khan IA, Schwartzman JD, Matsuura T, Kasper LH (1997). A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci U S A;94:13955-60. Khan IA (2007). Toll road for Toxoplasma gondii: the mystery continues. Trends Parasitol; 23(1):1-3. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB (2005). Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology;128:891-906. Kleanthous H, Lee CK, Monath TP (1998). Vaccine development against infection with Helicobacter pylori. Br.Med Bull. 54, 229-241. Kojouharoff G, Hans W, Obermeier F, Mannel DN, Andus T, Schölmerich J, Gross V, Falk W (1997). Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol; 107(2):353-8. Konstantinov SR, Fitzsimons N, Vaughan EE, Akkermans ADL (2002). From composition to functionality of the intestinal microbial communities. In: Probiotics and Prebiotics: where are we going ? Tannock GW, Ed. Caister Academic Press,

Wymondham, UK):

59-84. Kosiewicz MM, Nast CC, Krishnan A, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Kozaiwa K, Cominelli F (2001). Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease . J Clin Invest; 107:695-702. Kraft C, Suerbaum S (2005 ). Mutation and recombination in Helicobacter pylori: mechanisms and role in generating strain diversity. Int J Med Microbiol; 295(5):299-305. Kreiss C, Buclin T, Cosma M, Corthesy-Theulaz I, Michetti P (1996). Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection. Lancet;347(9015):1630-1. Kristensen NN, Brudzewsky D, Gad M, Claesson MH (2006). Chemokines involved in protection from colitis by CD4+CD25+ regulatory T cells. Inflamm Bowel Dis; 12(7):612-8. Lange S, Delbro DS, Jennische E, Mattsby-Baltzer I (1996). The role of the Lps gene in experimental ulcerative colitis in mice. APMIS;104(11):823-33. Lee DH, Zo YG, Kim SJ (1996). Non-radioactive method to study genetic profiles of natural bacterial communities by PCR-single-strand-conformation polymorphism. Appl Environ Microbiol;62:3112-3120. Lee SK, Josenhans C (2005). Helicobacter pylori and the innate immune system. Int J Med Microbiol; 295(5):325-34. Lee CW, Bennouna S, Denkers EY (2006). Screening for Toxoplasma gondii-regulated transcriptional responses in lipopolysaccharide-activated macrophages. Infect Immun; 74(3):1916-23. Lembo A, Kalis C, Kirschning CJ, Mitolo V, Jirillo E, Wagner H, Galanos C, Freudenberg MA (2003). Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in mice. Infect Immun; 71(10):6058-62. Leser TD, Amenuvor JZ, Jensen TK, Lindecrona RH, Boye M, Moller K (2002). Culture-independent analysis of gut bacteria: the pig gastrointestinal tract microbiota revisited. Appl. Environ. Microbiol; 68:673-690. Leveau P, Wang X, Soltesz V, Ihse I, Andersson R (1996). Alterations in intestinal motility and microflora in experimental acute pancreatitis . Int J Pancreatol; 20:119-25. Liesack W & Stackebrandt E (1992). Occurrence of novel groups of the domain Bacteria as revealed by analysis of genetic material isolated from an Australian terrestrial environment. J. Bacteriol; 174:5072–5078. Liesenfeld O, Kosek J, Remington JS, Suzuki Y (1996). Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med; 184:597-607. Liesenfeld O, Kang H, Park D, Nguyen TA, Parkhe CV, Watanabe H, Abo T, Sher A, Remington JS, Suzuki Y (1999a). TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol;21:365-76 Liesenfeld O (1999b). Immune responses to Toxoplasma gondii in the gut. Immunobiology;201:229-239. Liesenfeld O (2002). Oral Infection of C57BL/6 Mice with Toxoplasma gondii: A New Model of Inflammatory Bowel Disease? J Infect Dis; 185 (Suppl 1):S96–10 Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM (2004 ). Bacterial flagellin is a dominant antigen in Crohn’s disease. J Clin Invest; 113:1296–1306. Löhning M, Grogan JL, Coyle AJ, Yazdanbakhsh M, Meisel C, Gutierrez-Ramos JC,Radbruch A, Kamradt T (1999 ). T1/ST2 expression is enhanced on CD4+ T cells from schistosome egg-induced granulomas: analysis of Th cell cytokine coexpression ex vivo. J Immunol; 162(7):3882-9. Lucas B, Bumann D, Walduck A, Koesling J, Develioglu L, Meyer TF, Aebischer, T (2001). Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling . Infect.Immun. 69, 1714-1721. Lucke K, Miehlke S, Jacobs E, Schuppler M (2006). Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol; 55(Pt 5):617-24. Ludwig W, Strunk O, Klugbauer S, Klugbauer N, Weizenegger M, Neumaier J, Bachleitner M, Schleifer KH (1998). Bacterial phylogeny based on comparative sequence analysis. Electrophoresis;19:554-568. Ludwig W, Strunk O, Westram R, Richter L, Meier H, Yadhukumar, Buchner A, Lai T, Steppi S, Jobb G, Forster W, Brettske I, Gerber S, Ginhart AW, Gross O, Grumann S, Hermann S, Jost R, Konig A, Liss T, Lussmann R, May M, Nonhoff B, Reichel B, Strehlow R, Stamatakis A, Stuckmann N, Vilbig A, Lenke M, Ludwig T, Bode A, Schleifer KH (2004). ARB: a software environment for sequence data. Nucleic Acids Res;32(4):1363-71. Macagno A, Molteni M, Rinaldi A, Bertoni F, Lanzavecchia A, Rossetti C, Sallusto (2006 ). A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J Exp Med; 203(6):1481-92. MacDonald TT, Monteleone G (2001). IL-12 and Th1 immune responses in human Peyer’s patches. Trends Immunol 22;244. MacDonald TT, Monteleone G (2005). Immunity, inflammation, and allergy in the gut. Science;307(5717):1920-5. Madsen KL, Doyle JS, Tavernini MM, Jewell LD, Rennie RP, Fedorak RN (2000 ). Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology;118:1094-105. Madsen KL (2001). The use of probiotics in gastrointestinal disease. Can J Gastroenterol; 15(12):817-22. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001). Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology;121(3):580-91. Madsen K (2006 ). Probiotics and the immune response. J Clin Gastroenterol; 40(3):232-4. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P (1995). Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science;267(5204):1655-8. Marshall BJ, Warren JR (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet;1(8390):1311-5 Martin HM, Rhodes JM (2000). Bacteria and inflammatory bowel disease. Curr Opin Infect Dis; 13(5):503-509. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM ( 2004) Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology;127:80-93. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ (2006). Abnormal Microbiota Composition in the Ileocolonic Mucosa of Crohn's Disease Patients as Revealed by Polymerase Chain Reaction-Denaturing Gradient Gel Electrophoresis. Inflamm Bowel Dis; 12(12):1136-1145. Masseret E, Boudeau J, Colombel JF, Neut C, Desreumaux P, Joly B, Cortot A, Darfeuille-Michaud A (2001). Genetically related Escherichia coli strains associated with Crohn's disease. Gut;48:320-5. Massol-Deyá A, Weller R, Ríos-Hernández L, Zhou JZ, Hickey RF, Tiedje JM (1997 ). Succession and convergence of biofilm communities in fixed-film reactors treating aromatic hydrocarbons in groundwater. Appl Environ Microbiol 63:270-276. Matsumoto S, Okabe Y, Setoyama H, Takayama K, Ohtsuka J, Funahashi H, Imaoka A, Okada Y, Umesaki Y (1998). Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut;43(1):71-8. McGee HS, Agrawal DK (2006). TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma. Immunol Res; 35(3):219-32. McLoughlin RM, O'Morain CA, O'Connor HJ (2005). Eradication of Helicobacter pylori: recent advances in treatment. Fundam Clin Pharmacol; 19(4):421-7. Medvedev AE, Henneke P, Schromm A, Lien E, Ingalls R, Fenton MJ, Golenbock DT, Vogel SN (2001). Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4 . J Immunol; 167: 2257-2267 Medzhitov R, Janeway CA Jr (1997 ). Innate Immunity: The virtues of a nonclonal system of recognition. Cell;91:295-8. Medzhitov R, Janeway CA Jr (2000). Innate immunity. N Engl J Med; 343:338-344. Megraud F (1995). Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. Aliment Pharmacol Ther; 9(Suppl 2):85-91. Melgar S, Karlsson A, Michaelsson E (2005). Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol; 288(6):G1328-38. Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B,Arditi M, Abreu MT (2003). Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol; 170(3):1406-15. Mennechet FJ, Kasper LH, Rachinel N, Minns LA, Luangsay S, Vandewalle A, Buzoni-Gatel D (2004). Intestinal intraepithelial lymphocytes prevent pathogen-driven inflammation and regulate the Smad/T-bet pathway of lamina propria CD4+ T cells. Eur J Immunol; 34(4):1059-67. Merlin T, Sing A, Nielsen PJ, Galanos C, Freudenberg MA (2001). Inherited IL-12 unresponsiveness contributes to the high LPS resistance of the Lps(d) C57BL/10ScCr mouse. J Immunol; 166(1):566-73. Metzger WG, Mansouri E, Kronawitter M, Diescher S, Soerensen M, Hurwitz R, Bumann D, Aebischer T, Von Specht BU, Meyer TF (2004). Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine;22(17-18):2273-7. Michelsen, K., Aicher, A., Mohaupt, M., Kirschning, C.J.and Schumann RR (2001) Toll-like receptors (TLRs) are required for maturation of murine dendritic cells. J Biol Chem; 276:25680-25686. Michetti P, Corthesy-Theulaz I, Davin C, Haas R, Vaney AC, Heitz M, Bille J, Kraehenbuhl JP, Saraga E, Blum AL (1994). Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology;107(4):1002-11. Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthesy-Theulaz I, Losonsky G, Nichols R, Simon J, Stolte M, Ackerman S, Monath TP, Blum AL (1999). Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology;116(4):804-12. Minns LA, Menard LC, Foureau DM, Darche S, Ronet C, Mielcarz DW, Buzoni-Gatel D, Kasper LH (2006). TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J Immunol; 176(12):7589-97. Monstein HJ, Tiveljung A, Kraft CH, Borch K, Jonasson, J (2000). Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis. J.Med.Microbiol; 49:817-822. Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, Luzza F, Fusco A, Pallone F (1999). Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol; 163(1):143-7. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD (2001). Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol;167(8):4574-84. Moter A, Hoenig C, Choi BK, Riep B, Gobel UB (1998). Molecular epidemiology of oral treponemes associated with periodontal disease. J Clin Microbiol;36(5):1399-403. Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A, Wirz A, Preston T, McColl KE (2000). Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology; 119:339-347. Mowat C, McColl KE (2001). Alterations in intragastric nitrite and vitamin C levels during acid inhibitory therapy. Best Pract Res Clin Gastroenterol; 15(3):523-37. Mullarkey M, Rose JR, Bristol J, Kawata T, Kimura A, Kobayashi S, Przetak M, Chow J, Gusovsky F, Christ WJ, Rossignol DP (2003). Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Ther; 304(3):1093-102. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H (1992). Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Biotechnology;24:17-27. Mun HS, Aosai F, Norose K, Chen M, Piao LX, Takeuchi O, Akira S, Ishikura H, Yano A (2003). TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol; 15(9):1081-7. Mun HS, Aosai F, Norose K, Piao LX, Fang H, Akira S, Yano A (2005). Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasma gondii-derived heat shock protein 70 . Infect Immun; 73(8):4634-42. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL (2000). Signaling and transcription in T helper development. Annu Rev Immunol; 18:451-94. Murphy KM, Reiner SL (2002). The lineage decisions of helper T cells. Nat Rev Immunol; 2(12):933-44. Muyzer G, de Waal EC, Uitterlinden AG (1993). Profiling of complex microbial populations by denaturating gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol; 59:695-700. Muyzer G, Smalla K (1998). Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Anton. Leeuw; 73:127-141. Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR (2001). Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr; 32(4):449-53. Naumann M (2005). Pathogenicity island-dependent effects of Helicobacter pylori on intracellular signal transduction in epithelial cells. Int J Med Microbiol;295(5):335-41. Newman B, Siminovitch KA (2005). Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol; 21:401–407. Niebergall, Julia. Die Rolle von TLRs und bakterieller Antigen-Erkennung in der Immunpathogenese der akuten Ileitis und Colitis der Maus . Medizinische Dissertationsschrift, FU/HU Berlin, in Vorbereitung. Nio J, Fujimoto W, Konno A, Kon Y, Owhashi M, Iwanaga T (2004). Cellular expression of murine Ym1 and Ym2, chitinase family proteins, as revealed by in situ hybridization and immunohistochemistry. Histochem Cell Biol; 121(6):473-82. Nowrouzian F, Hesselmar B, Saalman R, Strannegard IL, Aberg N, Wold AE, Adlerberth I (2003). Escherichia coli in infants' intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatr Res; 54(1):8-14. Nübel U, Engelen B, Felske A, Snaidr J, Wieshuber A, Amann RI, Ludwig W, Backhaus H (1996). Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus polymyxa detected by temperature gradient gel electrophoresis. J Bacteriol; 178(19):5636-43. Obermeier F, Kojouharoff G, Hans W, Schölmerich J, Gross V, Falk W (1999). Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol; 116(2):238-45. Obermeier F, Dunger N, Strauch UG, Hofmann C, Bleich A, Grunwald N, Hedrich HJ, Aschenbrenner E, Schlegelberger B, Rogler G, Schölmerich J, Falk W. (2005). CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology;129:913-27. Odenbreit S (2005). Adherence properties of Helicobacter pylori: impact on pathogenesis and adaptation to the host. Int J Med Microbiol; 295(5):317-24. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn´s disease. Nature 411: 603-606. Ohkawara T, Takeda H, Nishihira J, Miyashita K, Nihiwaki M, Ishiguro Y, Takeda K, Akira S, Iwanaga T, Sugiyama T, Asaka M (2005). Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice. Clin Exp Immunol; 141(3):412-21. Okada Y, Tsuzuki Y, Miyazaki J, Matsuzaki K, Hokari R, Komoto S, Kato S, Kawaguchi A, Nagao S, Itoh K, Watanabe T, Miura S (2006). Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid(DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut;55(5):681-8. Okahara S, Arimura Y, Yabana T, Kobayashi K, Gotoh A, Motoya S, Imamura A, Endo T, Imai K (2005). Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis. Aliment Pharmacol Ther; 21(9):1091-7. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inahgaki Y, Nakaya R (1990). A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694–702. Onderdonk AB, Richardson JA, Hammer RE, Taurog JD (1998). Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun; 66:6022-3. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y (2003 ). Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol; 170:3977-3985. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, Timmis KN, Schreiber S. (2004). Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut;53:685-693. Otte JM, Cario E, Podolsky DK (2004). Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology;126(4):1054-70. Peek RM Jr, Blaser MJ (2002 ). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer; 2(1):28-37. Pizarro TT, Arseneau KO, Bamias G, Cominelli F. (2003). Mouse models for the study of Crohn's disease. Trends Mol. Med. 9:218-222. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science;282(5396):2085-8. Poltorak A, Merlin T, Nielsen PJ, Sandra O, Smirnova I, Schupp I, Boehm T, Galanos C, Freudenberg MA (2001). A point mutation in the IL-12R beta 2 gene underlies the IL-12 unresponsiveness of Lps-defective C57BL/10ScCr mice. J Immunol; 167(4):2106-11. Pounder RE, Ng D (1995). The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther;9:L33-39. Pulendran B, Palucka K, Banchereau J (2001). Sensing pathogens and tuning immune responses, Science;293:253-256. Pulz M, Matussek A, Monazahian M, Tittel A, Nikolic E, Hartmann M, Bellin T, Buer J, Gunzer F (2003). Comparison of a shiga toxin enzyme-linked immunosorbent assay and two types of PCR for detection of shiga toxin-producing Escherichia coli in human stool specimens. J Clin Microbiol;41(10):4671-5. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J, Takabayashi K, Raz E (2004). Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126:520-528. Radcliff FJ, Hazell SL, Kolesnikow T, Doidge C, Lee A (1997). Catalase, a novel antigen for Helicobacter pylori vaccination. Infect Immun; 65(11):4668-74. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell;118:229-241. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB (1996). Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest; 98:945-953. Rath HC, Ikeda JS, Linde HJ, Schölmerich J, Wilson KH, Sartor RB (1999a). Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology; 116:310-319. Rath HC, Wilson KH, Sartor RB (1999b). Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli . Infect Immun;( 6):2969-74. Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ, Schölmerich J, Sartor RB (2001). Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice . Infect Immun; 69:2277-85. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P (2001). Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunol; 2:361-7. Rescigno M, Chieppa M (2005). Gut-level decisions in peace and war. Nat Med;11(3):254-5. Rescigno M, Nieuwenhuis EE (2007). The role of altered microbial signaling via mutant NODs in intestinal inflammation. Curr Opin Gastroenterol; 23(1):21-6. Rioux KP, Madsen KL, Fedorak RN (2005). The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics. Gastroenterol Clin North Am;34(3):465-82. Rioux KP, Fedorak RN (2006). Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol; 40(3):260-3. Robben PM, Mordue DG, Truscott SM, Takeda K, Akira S, Sibley LD (2004). Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype . J Immunol; 172(6):3686-94. Rowland M & Drumm B (1998). Clinical significance of Helicobacter infection in children. Br Med Bull;54:95-103. Rossignol DP, Wasan KM, Choo E, Yau E, Wong N, Rose J, Moran J, Lynn M (2004). Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran (E5564) during continuous intravenous infusion into healthy volunteers. Antimicrob Agents Chemother; 48(9):3233-40. Rupnow MF, Owens DK, Shachter R, Parsonnet J (1999). Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology. Helicobacter;4(4):272-80. Rupnow MF, Shachter RD, Owens DK, Parsonnet J (2001). Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. Vaccine;20(5-6): 879-85. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA (2003). Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol; 170(6):3233-42. Sakagami T, Dixon M, O'Rourke J, Howlett R, Alderuccio F, Vella J, Shimoyama T, Lee A (1996). Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut;39(5):639-48. Salfinger M (1980). Possibilities and limits of the proof by culture of intestinal bacterial infections. Ther. Umsch. 37: 181-186. Salzman NH, De Jong H, Paterson Y, Harmsen HJ, Welling GW, Bos NA (2002). Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology;148:3651-3660. Sambrook J, Fritsch EF, Maniatis T (1989). Molecular Cloning: A Laboratory Manual . Cold Spring Harbor Laboratory Press,

NY,

Vol. 1, 2, 3. Sartor RB (1995). Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am; 24:475-507. Sartor RB (1997). Review article: How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment Pharmacol Ther 11 (Suppl 3):89-97. Sartor RB (1997a). The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol; 148(8-9):567-76. Sartor RB (2004). Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology;126:1620-1633. Sartor RB (2005). Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol;21:44-50. Sartor RB (2006). Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol; 3(7):390-407. Scanga CA, Aliberti J, Jankovic D, Tilloy F, Bennouna S, Denkers EY, Medzhitov R, Sher A (2002). Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol;168(12):5997-6001. Schultz M, Tonkonogy SL, Sellon RK, Veltkamp C, Godfrey VL, Kwon J, Grenther WB, Balish E, Horak I, Sartor RB (1999 ). IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol;276(6 Pt 1):G1461-72. Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Gottl C, Dunger N, Grunwald N, Schölmerich J, Rath HC (2004). Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin. Diagn. Lab. Immunol. 11:372-378. Schuppler M, Lotzsch K, Waidmann M, Autenrieth IB. (2004). An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice . Infect Immun;72:1983-1990. Segal ED, Shon J, Tompkins LS (1992). Characterization of Helicobacter pylori urease mutants. Infect Immuno; 60:1883-1889. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J (2003). Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut;52:237-242. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun; 66(11):5224-31. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J (2000). Quantitation of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol; 66: 2236-6 Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, Dinarello CA, Endres S, Eigler A (2001). Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol; 281:R1264-1273 Silverman N, Maniatis T (2001). NF- κ B signaling pathways in mammalian and inst innate immunity. Genes & Dev; 15:2321-42 Simon GL, Gorbach SL (1984). Intestinal flora in health and disease. Gastroenterology;86:174-193. Sokol H, Lepage P, Seksik P, Dore J, Marteau P (2006a). Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol; 44(9):3172-7. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, Marteau P, Dore J (2006b). Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis; 12(2):106-11. Solnick JV, Josenhans C, Suerbaum S, Tompkins LS, Labigne A (1995). Construction and Characterization of an isogenic urease-negative mutant of Helicobacter mustelae. Infect Immun; 63:3718-3721. Stingl K, De Reuse H (2005 ). Staying alive overdosed: how does Helicobacter pylori control urease activity? Int J Med Microbiol; 295(5):307-15. Strober W (2004). Epithelial cells pay a Toll for protection. Nat Med; 10(9):898-900. Suerbaum S, Michetti P (2002). Helicobacter pylori infection. N Engl J Med; 347:1175–1186. Sun YQ, Monstein HJ, Nilsson LE, Petersson F, Borch K (2003). Profiling and Identification of Eubacteria in the Stomach of Mongolian Gerbils With and Without Helicobacter pylori Infection. Helicobacter;8:149-157. Sun YQ, Petersson F, Monstein HJ, Soderholm JD, Rehfeld JF, Borch K ( 2005). Long-term morpho-functional development of Helicobacter pylori-induced gastritis in Mongolian gerbils. Scand J Gastroenterol; 40(10):1157-67. Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, Yamamoto H, Chazin WJ, Nakatani Y, Yui S, Makino H (2006). The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther;8(3):R69. Sundberg JP, Elson CO, Bedigian H, Birkenmeier EH (1994 ). Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology;107(6):1726-35. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E (2000 ). IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol; 164:5375–82. Suzuki M, Hisamatsu T, Podolsky DK (2003). Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun; 71(6):3503-11. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M, Lochs H (2002). Mucosal flora in inflammatory bowel disease. Gastroenterology; 122:44-54. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H (2005). Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol;43:3380-9. Takeda K, Kaisho T, Akira S (2003). Toll-like receptors. Annu Rev Immunol 21:335-376. Takeda K (2005). Evolution and integration of innate immune recognition systems: the Toll-like receptors. J Endotoxin Res; 11(1):51-5. Tannock GW, Savage DC (1974). Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect.Immun;9: 591-598. Tannock GW (1999). Analysis of the intestinal microflora: a renaissance. Anton. Leeuw; 76(1-4):265-78. Tannock GW (2001). Molecular assessment of intestinal microflora. Am J Clin Nutr; 73(2 Suppl): 410S-414S. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, Vasiliauskas E, Elson CO, Hershberg RM (2005). Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn’s disease. Gastroenterology; 128:2020–2028 Tarpila E, Nystrom PO, Franzen L, Ihse I (1993). Bacterial translocation during acute pancreatitis in rats. Eur J Surg; 159:109-13. Thompson-Chagoyan OC, Maldonado J, Gil A (2005). Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin Nutr;24(3):339-52. Tlaskalova-Hogenova H, Tuckova L, Mestecky J, Kolinska J, Rossmann P, Stepankova R, Kozakova H, Hudcovic T, Hrncir T, Frolova L, Kverka M (2005a). Interaction of mucosal microbiota with the innate immune system . Scand J Immunol; 62 Suppl 1:106-13. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, Kozakova H, Rossmann P, Bartova J, Sokol D, Funda DP, Borovska D, Rehakova Z, Sinkora J, Hofman J, Drastich P, Kokesova A (2005b). Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett; 93(2-3):97-108. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C (2004). Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol;112:85-91. Torsvik V, Goksoyr J, Daae FL (1990a). High diversity in DNA of soil bacteria. Appl Environ Microbiol; 56(3):782-7. Torsvik V, Salte K, Sorheim R, Goksoyr J (1990b). Comparison of phenotypic diversity and DNA heterogeneity in a population of soil bacteria. Appl Environ Microbiol;56(3):776-81. Torsvik V, Daae FL, Sandaa RA, Ovreas L (1998). Novel techniques for analysing microbial diversity in natural and perturbed environments. J Biotechnol;64(1):53-62. Torsvik V, Ovreas L (2002). Microbial diversity and function in soil: from genes to ecosystems. Curr Opin Microbiol; 5(3):240-5. Trebesius K, Panthel K, Strobel S, Vogt K, Faller G, Kirchner T, Kist M, Heesemann J, Haas R (2000). Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut 46, 608-614. Tsubery H, Ofek I, Cohen S, Fridkin M (2000). The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide. Biochemistry; 39:11837-44. Tsubery H, Ofek I, Cohen S, Fridkin M (2000a). Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria. J Med Chem;43(16):3085-92. Tsubery H, Ofek I, Cohen S, Eisenstein M, Fridkin M (2002). Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. Mol Pharmacol;62(5):1036-42. Tsubery H, Yaakov H, Cohen S, Giterman T, Matityahou A, Fridkin M, Ofek I (2005). Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria. Antimicrob Agents Chemother; 49(8):3122-8. Tsuzuki H, Tani T, Ueyama H, Kodama M (2001). Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappa B in peripheral blood mononuclear cells, even during activation. J Surg Res;100:127-34. Uematsu S, Akira S (2006). Toll-like receptors and innate immunity. J Mol Med;84(9):712-25. Vakil N (2005) Primary and sondary treatment for Helicobacter pylori in the United States. Rev Gastroenterol Disord; 5:67–72. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA (2003). Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol;171(5):2602-9. Van de Merwe JP, Stegemann JH, Hazenberg MP (1983). The resident fecal flora is determined by genetic characteristics of the host. Implications for Crohn´s disease ? Ant. Leeuw;49 :119 Vaughan EE, Schut F, Heilig HG, Zoetendal EG, De Vos WM & Akkermans AD (2000). A molecular view of the intestinal ecosystem. Curr Iss Intest Microbiol;1:1–12. Vogel SN, Hansen CT, Rosenstreich DL (1979). Characterization of a congenitally LPS-resistant, athymic mouse strain. J Immunol;122(2):619-22. Von Wintzingerode F, Göbel UB, Stackebrandt E (1997). Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev;21:213-229. Waidmann M, Bechtold O, Frick JS, Lehr HA, Schubert S, Dobrindt U, Loeffler J, Bohn E, Autenrieth IB (2003). Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology;125:162-77. Wallin RPA, Lundqvist A, More SH, von Bonin A, Kiessling R, Ljunggren HG (2002). Heat shock proteins as activators of the innate immune system. Trends Immunol;23:130. Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM, Munro K, Alatossava T (2000). Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol;66(1):297-303. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP (2001). Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol;67(6):2578-85. Wang XD, Guo WD, Wang Q, Andersson R, Ekblad E, Soltesz V, Bengmark S (1994). The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal liver resection or portal vein obstruction in rats . Eur J Surg; 160:153-60. Ward DM, Weller R, Bateson MM (1990). 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community. Nature;345:63–65. Ward DM (1998). A natural species concept for prokaryotes. Curr Opin Microbiol; 1:271–277. Warren HS, Kania SA, Siber GR (1985). Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide. Antimicrob Agents Chemother;28:107-12. Watanabe T, Kitani A, Murray PJ, Strober W (2004). NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol;5:800-808. Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991). 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol;173:697-703. Welsh J, McClelland M (1990 ). Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res; 18(24):7213-8. Werts C, Tapping RI, Mathison JC, Chuang TH, Kravchenko V, Saint Girons I, Haake DA, Godowski PJ, Hayashi F, Ozinsky A, Underhill DM, Kirschning CJ, Wagner H, Aderem A, Tobias PS, Ulevitch RJ (2001 ). Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol; 2(4):346-52. Williams C (2001). Occurrence and significance of gastric colonization during acid-inhibitory therapy . Best Pract Res Clin Gastroenterol; 15, 511-521. Wirtz S, Neurath, MF (2000). Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis;15:144-60 Xia X, Bollinger J, Ogram A (1995). Molecular genetic analysis of the response of three soil microbial communities to the application of 2,4-D. Mol Ecol;4:17-28. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A (2005 ). TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science;308 (5728):1626-9. Yarovinsky F, Sher A (2006). Toll-like receptor recognition of Toxoplasma gondii. Int J Parasitol;36(3):255-9. Zanin-Zhorov A, Bruck R, Tal G, Oren S, Aeed H, Hershkoviz R, Cohen IR, Lider O (2005). Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines . J Immunol;174(6):3227-36. Zanin-Zhorov A, Cahalon L, Tal G, Margalit R, Lider O, Cohen IR (2006). Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest;116(7):2022-32. Zavros Y, Rieder G, Ferguson A, Merchant JL (2002a). Gastritis and hypergastrinemia due to Acinetobacter lwoffii in mice. Infect.Immun; 70:2630-2639. Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL (2002b). Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology; 122:119-133. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S (2004). A toll-like receptor that prevents infection by uropathogenic bacteria. Science; 303(5663):1522-6. Zhou JS, Friend DS, Feldweg AM, Daheshia M, Li L, Austen KF, Katz HR (2003 ). Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils . J Exp Med; 198(8):1243-51. Zoetendal EG, Akkermans AD, De Vos WM (1998). Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol; 64(10):3854-9. Zoetendal EG, Ben-Amor K, Akkermans AD, Abee T, de Vos WM (2001). DNA isolation protocols affect the detection limit of PCR approaches of bacteria in samples from the human gastrointestinal tract. Syst Appl Microbiol;24(3):405-10. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM (2002a). Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol;68(7):3401-7. Zoetendal EG, Ben-Amor K, Harmsen HJ, Schut AD, Akkermans AD, de Vos WM (2002b). Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes. Appl Environ Microbiol; 68(9):4225-32. Zoetendal EG, Cheng B, Koike S, Mackie RI (2004a). Molecular microbial ecology of the gastrointestinal tract: from phylogeny to function. Curr Issues Intest Microbiol;5(2):31-47. Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR (2004b). Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr; 134(2):465-72. Zoetendal EG, Vaughan EE, de Vos WM (2006). A microbial world within us. Mol Microbiol;59(6):1639-50.